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Abstract
The Tomb of the Shroud is a first-century C.E. tomb discovered in Akeldama, Jerusalem, Israel that had been illegally entered
and looted. The investigation of this tomb by an interdisciplinary team of researchers began in 2000. More than twenty
stone ossuaries for collecting human bones were found, along with textiles from a burial shroud, hair and skeletal remains.
The research presented here focuses on genetic analysis of the bioarchaeological remains from the tomb using
mitochondrial DNA to examine familial relationships of the individuals within the tomb and molecular screening for the
presence of disease. There are three mitochondrial haplotypes shared between a number of the remains analyzed
suggesting a possible family tomb. There were two pathogens genetically detected within the collection of osteological
samples, these were Mycobacterium tuberculosis and Mycobacterium leprae. The Tomb of the Shroud is one of very few
examples of a preserved shrouded human burial and the only example of a plaster sealed loculus with remains genetically
confirmed to have belonged to a shrouded male individual that suffered from tuberculosis and leprosy dating to the first-
century C.E. This is the earliest case of leprosy with a confirmed date in which M. leprae DNA was detected.
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Introduction
The Tomb of the Shroud was investigated in 2000 in the lower
Hinnom Valley at the foot of Mount Zion by an archaeological
team led by Shimon Gibson, Boaz Zissu and James Tabor [1,2].
The tomb had been entered and looted before archaeologists
reached the site. The tomb was one of more than seventy separate
family tombs of the first century C.E. in an area identified with
traditional Akeldama, the ‘‘Field of Blood’’ described in the Bible
(Matthew 27:3–8; Acts 1:19). The tomb comprised a simple
entrance cut into a quarried scarp leading to rectangular rock-
hewn chambers on two levels, with tunnel-like kokhim in the walls
and with a number of niche repositories - ossilegia is the custom of
bone collection in rock-hewn tombs - for the secondary storage of
human remains (Figure 1). More than twenty stone ossuaries for
the collection of human bone were found, a few bearing
inscriptions in Jewish and Greek script (‘‘Mary’’; ‘‘Shimon ben
[son of] Shulai’’; ‘‘Salome’’; ‘‘Phineas’’). What marked this tomb
as unique from the other tombs in the Akeldama cemetery was the
discovery of degraded shroud textile, with a simple weave and a
clump of human hair, in one of the loculi together with the skeletal
remains of a primary burial of an adult. This discovery is rare
because high levels of humidity in the Jerusalem area does not
usually allow for the preservation of organic material. A
radiocarbon date of the shroud textile determined by the AMS
radiocarbon laboratory in Texas (by D. Donahue) confirmed its
early date: 2025+/2 28 years BP, with calibrated calendar date
ranges of one sigma: 50 BCE -16 CE and two sigma: 95 BCE -53
CE.
The investigation of this tomb has included many areas of
archaeological investigation and the genetic analysis of the
bioarchaeological material from the Tomb of the Shroud was an
integral aspect of this interdisciplinary analysis. The genetic
analysis was performed because no other first century tomb from
Jerusalem has ever been examined by molecular methods and
this particular tomb has remains that are unique within this
region - specifically the discovery of textiles that form part of a
burial shroud from the first century. Also, due to the extremely
disturbed nature of the tomb, extensively damaged osteological
remains and recovery of less than 5% of each skeleton, traditional
morphological analysis did not yield any information (MNI,
height, age, sex, ancestry and pathology). The morphological
analysis did identify one osteological element, a phalanx (from
the hand), that presented with secondary osseous remodeling
lesions, however these features were not pathognomonic for any
disease (Figure 2). Since molecular analysis has proven to be
successful for the detection of Mycobacterium tuberculosis and
Mycobacterium leprae and these pathologies could be included in
the differential diagnosis of this osteological element, all the
samples in the tomb were screened for the presence of DNA from
these two pathogens. Mitochondrial DNA (mtDNA) was
analyzed to examine familial relationships of the individuals
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that identified the presence of disease. Genetic analysis involves a
method termed polymerase chain reaction (PCR) for amplifica-
tion and analysis of trace amounts of DNA, including pathogenic
bacterial DNA, recovered from past human material and has
been used successfully to identify and characterize ancient DNA.
The recovery of ancient or degraded DNA is challenging and
hindered by forms of damage, including chemical modifications
and fragmentation of the DNA [3,4,5]. The mtDNA molecule
has been used extensively for population analysis and the
identification of maternal relationships. MtDNA is favoured
over genomic DNA, with good recovery due to its high copy
number that is over a thousand copies within each cell
[3,6,7,8,9,10]. Mitochondria are maternally inherited organelles,
suitable for characterization of maternal relationships [11,12],
the traditional approach in familial genetics, identifying haplo-
types and population groups [10,13,14,15].
The first pathogenic DNA recovered from archaeological
remains was M. tuberculosis [16]. This was quickly followed by
the first report of M. leprae DNA in human remains from the
seventh century C.E. [17,18]. With recent advances in molecular
detection of pathogens, research has focused on historically
documented diseases and epidemics, although reports are still
dominated by analyses of M. tuberculosis [19,20,21], and of M.
leprae, the causative agent of leprosy (Hansen’s disease) [22,23,24].
The preservation and persistence of ancient bacterial DNA in the
archaeological record is controversial [25], however research into
the mechanisms bacteria use for self preservation during periods of
sub-optimal environmental conditions has provided supporting
evidence for the long term preservation [26] and stability of DNA
in bacterial pathogens.
Historically disfiguring diseases, particularly leprosy and
tuberculosis, were commonly categorized together in the Near
East and the afflicted individuals were ostracized from their
Figure 1. A schematic plan of the tomb (numbers represents the niche or loculi) (Produced by SG).
doi:10.1371/journal.pone.0008319.g001
Tomb of the Shroud Genetics
PLoS ONE | www.plosone.org 2 December 2009 | Volume 4 | Issue 12 | e8319communities. The general Jewish practice in the first century C.E.
was for a primary burial to be placed within a loculus until the
decomposition of organic remains had taken place, at which point
- approximately a year later - the bones were then taken out of the
loculus and transferred into a repository (a pit or wall niche) or into
a stone ossuary. However this transfer did not occur for the
individual buried in Tomb of the Shroud loculus 1 - instead this
loculus was sealed with white plaster, a practice which is quite rare
in the first century tombs studied around Jerusalem.
Materials and Methods
Permission for this research was provided by the Israeli
Antiquities Authority and the archaeologists who excavated the
material. Standard molecular archaeology protocols were applied
for analysis of the Tomb of the Shroud samples at the ancient
DNA laboratory in the Kuvin Centre for Tropical and Infectious
Diseases, Hebrew University (Israel) and replicated at the Paleo-
DNA Laboratory, Lakehead University (Canada) and at the
Department of Infection, University College London (UK).
Archaeological Sample Selection
In this study of the Tomb of the Shroud (SC) there were 23
samples tested for genetic relatedness or similarity based on the
mtDNA and disease, in addition three environmental matrix
controls of sediment that had built up in the rock hewn tomb
(Figure 1).
Microscopic examination of organic remains from the tomb
identified at least one piece of bone supporting uncharacteristic
osseous lesions that are not a product of the taphonomic
environment. The identification of the causative agent for the
lesion is hindered by the disturbed nature of the skeletal remains
(caused by the illegal looters of the tomb), and limited preservation
of skeletal elements, especially those in association with the
affected region. Tuberculosis is the primary candidate for causing
these lesions, and was the molecular focus of the pathological
analysis. Pathological lesions and bone resorption of the phalanges
typical for leprosy, was not observed in the few phalanges
recovered from the shroud loculus (SC1), however, the co-
infection of two mycobacterial diseases is not uncommon and has
been previously identified [27]. Skeletal remains from numerous
loculi were analyzed for the presence of M. tuberculosis. Teeth,
textile and bone samples were selected, with seven samples from
the shroud loculus (selected from the length of the loculi, SC1) to
maximize the chance of analyzing bone infected with a pathogenic
disease. Sediment samples from around the tomb and scrapings
from the rock walls and loculus roof were analyzed for the
presence of any pathogenic mycobacterial DNA or environmental
DNA causing non-specific results.
Genetic Analyses
Laboratory 1: The ancient DNA laboratory at the Kuvin
Centre for Tropical and Infectious Diseases, Hebrew
University, Israel. The extraction of DNA from the bone
samples used prepared aliquots of the sample. These were first
placed under UV irradiation with 254 nm wavelength for 24–
48 hours, depending on the size of the sample, to crosslink any
surface contaminating DNA from soil bacteria or handling. To
ensure there was no contamination, bone material from inside the
bone was removed by a dental pick while the surface of the bone
was left intact. The removed bone particles were placed into a
mortar and pestle, ground into a fine powder then placed into a
sterile tube for extraction. The working area was bleached and
washed with 3.0% (w/v) sodium hypochlorite solution followed by
70% ethanol before and after each sample preparation and all
equipment was sterilized before use. The equipment and the work
area were UV-irradiated prior to each preparation. The
researchers adhered to all standard ancient DNA and forensic
protocols including the use of laboratory coats, sleeves, double
gloving and face mask with frequent changes of gloves.
The prepared sample, approximately 25 mg was placed in a
1.5 ml tube containing 500 ml of guanidine thiocyanate (GuSCN)
solution (4.0 M GuSCN, 0.1 M tris-HCl pH 6.4, 20 mM EDTA
pH 8.0, 1.3% Triton X-100) and vortexed for 1 minute then
incubated at 56uC overnight under gentle agitation (modified from
Boom et al. 1990 [28]). The following day the preparation was
heated at 94uC for 10 minutes, centrifuged (3 minutes at 15,000 x
g) and the supernatant transferred to another sterile 1.5 ml tube.
Guanidine thiocyanate solution (1.0 ml) and silica bead (Sigma)
suspension (10 ml), prepared as outlined by Boom et al. 1990 [28],
were added to the sample. The tube was mixed for 20 seconds and
placed on ice for 1 hour with agitation every 15 minutes. The
sample was centrifuged at 15,000 x g or 30 seconds and the
supernatant discarded carefully. Next, 500 ml of washing buffer
(2.0 mM tris-HCl pH 7.5, 10 mM EDTA pH 8.0, 10 mM NaCl,
50% (v/v) water, 50% (v/v) ethanol) was added, mixed and
centrifuged (30 seconds at 12,000 x g). The supernatant was
discarded. The wash buffer step was repeated, if the pellet was
discolored. The silica pellet was washed with 200 ml absolute
ethanol as above and allowed to air dry. DNA was eluted with
150 ml of sterilized water, mixed for 20 seconds and incubated at
Figure 2. The phalanx with suspected pathology (Photograph
taken by KKV).
doi:10.1371/journal.pone.0008319.g002
Tomb of the Shroud Genetics
PLoS ONE | www.plosone.org 3 December 2009 | Volume 4 | Issue 12 | e831956uC for at least 1 hour then resuspended in sterilized water. The
sample was centrifuged (3 minutes at 15,000 x g) and the DNA
extract stored at 4uC. The whole procedure was performed with
extraction negatives to ensure that no contamination had entered
the samples during this process. Standard precautions to minimize
contamination were employed, sterile tubes and plugged tips
under UV hoods where PCR reagent preparations were physically
separated, from both sample preparation and PCR, in separate
rooms with separate air supply. All equipment and surfaces were
washed with a 3.0% (w/v) sodium hypochlorite solution and UV
irradiated at 254 nm wavelength between each use.
The PCR was in a final volume of 25 ml (consisting of: 200 mM
tris-HCl pH 8.4, 500 mM KCl, 2.0 mM MgCl2, 2.5 mM of each
nucleotide (dATP, dCTP, dGTP and dTTP), 0.25 mM of each
primer, 1.25 units of Platinum Taq DNA polymerase (Invitrogen).
The DNA extract (10.0 ml) was added to each tube and both
negative and positive controls were always included. The positive
control DNA was diluted to simulate ancient DNA concentrations
and was added to the positive control reaction tubes in a separate
room from where the PCR reactions were prepared, before being
loaded onto the thermal cycler. The amplification program
consisted of a 3 minutes initial denaturation at 94uC, followed
by 45 cycles of: 94uC for 1 minute, 60uC for 1 minute and 72uC
for 2 minute; followed by 10 minute at 72uC. Mitochondrial DNA
primers for the Hypervariable region 1 (HV1) were used [29,30]
and sexing primers [31]. Primers were designed for the analysis of
Hypervariable region 2 (HV2) (Table 1). Molecular analysis for sex
identification was performed because the remains were too
incomplete and fragmented to identify the sex of the individuals
through morphological analysis.
There were multiple sets of primers used for the analysis of the
multicopy IS6110 target region: one PCR which used IS6110
primers [32] for a slightly longer target of 246 bp; another set of
primers [33] that amplify a 123 bp product and a third set used in
conjunction with the former for a nested PCR [20] which give a
92 bp product. These multiple primer sets were included to
address fragmentation. A second genetic region of amplification
was used for the detection on M. tuberculosis, with primers [34] that
target a 203 bp region in the ribosomal protein S12 gene (Table 1).
M. leprae DNA was amplified using primers for the multicopy
Table 1. The mitochondrial DNA, sex and disease primers used in this study.
Organisim Name Target region Primer Sequence (59 –3 9) Reference
H. sapiens mt15975F mtDNA Hypervariable Region 1 CTCCACCATTAGCACCCAAAGC [29]
mt16190F mtDNA Hypervariable Region 1 CCCATGCCTACAAGCAAGTA [51]
mt16322R mtDNA Hypervariable Region 1 TGGCTTTATGTACTATGTACTG [30]
mt16420R mtDNA Hypervariable Region 1 TGATTTCACGGAGGATGGTG [29]
mt1F mtDNA Hypervariable Region 2 GATCACAGGTCTATCACCC [36]
mt15F mtDNA Hypervariable Region 2 CACCCTATTAACCACTCACG [52]
mt155F mtDNA Hypervariable Region 2 TATTTATCGCACCTACGTTC [36]
mt279R mtDNA Hypervariable Region 2 GATGTCTGTGTGGAAAGTGG [36]
mt429R mtDNA Hypervariable Region 2 CTGTTAAAAGTGCATACCGCCA [29]
Amel1 Amelogenin gene CCCTGGGCTCTGTAAAGAATAGTG [31]
Amel2 Amelogenin gene ATCAGAGCTTAAACTGGGAAGCTG [31]
ARXF X chromosome Alphoid Repeat AATCATCAAATGGAGATTTG [53]
ARXR X chromosome Alphoid Repeat GTTCAGCTCTGTGAGTGAAA [53]
ARYF Y chromosome Alphoid Repeat ATGATAGAAACGGAAATATG [53]
ARYR Y chromosome Alphoid Repeat AGTAGAATGCAAAGGGCTCC [53]
M. tuberculosis INS.1 IS6110 repeat element CGTGAGGGCATCGAGGTGGC [32]
INS.2 IS6110 repeat element GCGTAGGCGTCGGTGACAAA [32]
P1 IS6110 repeat element CTCGTCCAGCGCCGCTTCGG [33]
P2 IS6110 repeat element CCTGCGAGCGTAGGCGTCGG [33]
IS3 IS6110 repeat element TTCGGACCACCAGCACCTAA [20]
IS4 IS6110 repeat element TCGGTGACAAAGGCCACGTA [20]
S12.F Ribosomal protein S12 gene CGTCGGGACAAGATCAGTAAG [54]
S12.R Ribosomal protein S12 gene CAACCTGCAGGAGCACTCGAT [54]
M. leprae LP1 RLEP repetitive element TGCATGTCATGGCCTTGAGG [24]
LP2 RLEP repetitive element CACCGATACCAGCGGCAGAA [24]
LP3 RLEP repetitive element TGAGGTGTCGGCGTGGTC [24]
LP4 RLEP repetitive element CAGAAATGGTGCAAGGGA [24]
LP5 18kDa Antigen gene ATCGACTGTTGTTTGCGCAAC [24]
LP6 18kDa Antigen gene CCAGCAACCGAAATGTTCGGA [24]
LP7 18kDa Antigen gene TCATAGATGCCTAATCGACTG [24]
LP8 18kDa Antigen gene GGCACATCTGCGGCCAGCA [24]
doi:10.1371/journal.pone.0008319.t001
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set of primers [24] that targets a region of the 18 kDa antigen gene
(Table 1).
PCR product (10 ml) was added to 1.0 ml loading dye (MBI
Fermentas) and electrophoresed in a 2.0% (w/v) NuSieve (FMC
Bioproducts) in TAE (40 mM Tris, 20 mM acetic acid, 1.0 mM
EDTA pH 8.0) at 108 volts for 35 minutes. Amplified DNA was
visualized by ethidium bromide (0.8 mg/ml) staining exposed
to ultraviolet light, recorded with digital imaging equipment
(Pharmacia Biotech, ImageMaster).
PCR product was excised from the NuSieve gel and was
amplified on a sequencing reaction of 50 cycles of 95uC for 30
seconds, 55uC for 30 seconds and 72uC for 1 minute. The product
was directly sequenced on 6% polyacrylamide gel using a
radioactive manual sequencing kit (Sequenase Kit, Amersham)
and exposed to X-ray film (Kodak) to visualize.
Laboratory 2: The Paleo-DNA Laboratory, Lakehead
University, Canada. Each sample was mechanically cleaned
with a 10% detergent (Tergazyme) solution. They were then
rinsed with a 6.0% (w/v) sodium hypochlorite solution followed by
70% ethanol. The teeth were then sprayed with sterilized water
and exposed to UV light at 254 nm wavelength and a distance of
30 cm for 20 minutes on all sides. This was done to damage any
possible surface contaminants or modern exogenous DNA. To
ensure there was no contamination, bone material from inside the
bone was removed by a dental pick while the surface of the bone
was left intact. The removed bone particles were placed into a
mortar and pestle and ground into a fine powder then placed into
a sterile tube for extraction. The surface of the tooth samples were
removed then pulverized using a steel chamber and Retsch mixer
mill and aliquots were placed into sterile 1.5 ml microcentrifuge
tubes where they remained dry at room temperature until
extraction.
DNA extraction was performed using two methods. The first
was a modified Hansen et al. [35] extraction method, where
approximately 0.3 g of tooth or bone powder was suspended in
400 ml of a proteinase K extraction buffer (0.5 M NaCl, 0.5 M
EDTA, 1.0 M tris-HCl pH 8.0, 0.2% SDS, 0.039 M DTT,
0.1 mg/ml proteinase K). Extractions were carried out for
15 hours at 37uC under gentle agitation. Following the initial
proteinase K extraction, a phenol-chloroform separation was
conducted, followed by purification and concentrating the extracts
using ethanol precipitation. The second extraction method used
was a modified Boom et al. [28] method where approximately
0.3 g of tooth powder was suspended in 500 ml of a guanidinium
thiocyanate (GuSCN) extraction buffer (4.0 M GuSCN, 0.1 M
tris-HCl pH 6.4, 0.02 M EDTA pH 8.0, 1.3% triton X-100) for
15 hours at 56uC under gentle agitation. Following this extraction,
the samples were purified using 20 ml of a silica suspension, which
was then washed with 500 ml of working wash buffer (10 mM tris-
HCl pH 7.5, 50 mM NaCl, 1.0 mM EDTA, 50% EtOH) and
150 ml of 100% ethanol. The samples were then dried with the
DNA bound to the silica until amplification was performed. When
required they were resuspended in sterilized water and incubated
at 56uC for at least 1 hour. An additional purification was found to
remove the inhibition and was conducted on all the samples using
Micro Bio-spin P-30 size exclusion chromatography columns
(BIO-RAD Laboratories)[36].
The amplification of fragments within HV1 and HV2 of the
mitochondrial genome, M. tuberculosis, M. leprae and the amelo-
genin and alphoid repeats within the nuclear genome were
performed (Table 1). The mitochondrial hypervariable regions
were amplified with multiple sets of primers between 100 bp and
350 bp. These combinations of primers were mt15975F and
mt16322R (347 bp), mt16190F and mt16420R (230 bp), mt1F or
mt15F and mt279R (278 bp or 264 bp respectively) and mt155F
and mt439R (284 bp). The M. tuberculosis specific primer sets
included the INS.1 and the INS.2 and the S12.F and the S12.R
primer pairs. The M. leprae specific primers were usually
performed with the LP1 and LP2 and the LP5 and LP6 primers.
Sometimes the nested PCR was performed using the LP3 and LP4
and the LP7 and the LP8 primers. The amelogenin primers were
used to identify the sex of the remains along with the alphoid
repeats, however the amelogenin is an amplified fragment length
product (AFLP) where the alphoid repeats were genetic target of
the X or the Y chromosome specifically.
The PCRs were prepared using 1X PCR Buffer, 2.0 mM
MgCl2, 200 mM dNTPs (Invitrogen), 0.2 mM of each primer, and
1 unit of platinum Taq DNA polymerase (Invitrogen). The
remaining volume was created using sterilized water and DNA
template to total a 25 ml reaction. The amplification cycling
parameters were as follows: 94uC for 3 minutes, followed by 45
cycles of 94uC for 30 seconds; 60uC for 1 minute; and 72uC for 2
minutes. PCR products were then analyzed using 6% polyacryl-
amide gel electrophoresis (PAGE) and stained with ethidium
bromide (0.8 mg/ml). Prior to sequencing, the PCR products were
purified using the QIAquick PCR purification kits (QIAGEN).
DNA fragments were then sequenced using the ABI Big DyeH
Terminator v3.1 cycle sequencing kit (Applied Biosystems)
according to the manufacturer’s protocol. Forward and reverse
sequencing reactions were conducted for all PCR products.
Cycling parameters used for sequencing reactions were as follows:
35 cycles of 94uC for 30 seconds; 50uC for 15 seconds; and 72uC
for 4 minutes. Sequences were then analyzed using an ABI
PRISM 3100 Genetic Analyzer (Applied Biosystems). The
sequences were aligned using the BioEdit Sequence Alignment
Editor (Tom Hall, Ibis Therapeutics). They were aligned and
compared using the revised Cambridge reference sequence and
the corresponding M. tuberculosis and M. leprae targets to determine
the presence of polymorphisms [37,38].
The Paleo-DNA Laboratory is a dedicated ancient DNA facility
with stringent precautions and protocols employed for the analysis
of degraded DNA. The facility has separated pre-PCR, post-PCR
and PCR areas all with separate air handling systems. The pre-
PCR area (clean laboratory) is further divided into separate rooms
for each analytical task (reagents preparation, samples preparation
and PCR preparation) and each work station has dedicated
equipment. The researcher wears full body tyvek suits, mask,
hoods, booties, eye protection, hair nets underneath and gloves
including additional booties, sleeves and gloves over the top of the
primary layer. They enter the clean laboratory through an air
shower to remove particulates and debris. All reagents, consum-
ables and implements are sterilized in a separate dedicated room
(reagent preparation) where detergent soaks, bleach soaks,
sonication, baking, autoclaving and cross-linking are used for
sterilization. All work surfaces and equipment are cleaned before
and after use, daily and the entire laboratory is sterilized weekly.
Laboratory controls are taken every month, where all the surfaces
are swabbed and analyzed for contamination. The Paleo-DNA
Laboratory also carries out forensic case work and follows strict
standard operating procedures (SOPs).
Laboratory 3: The Centre for Infectious Diseases and
International Health, University College London, UK. The
amplification of the M. tuberculosis and M. leprae procedure was
replicated in London on samples of the SC1 and SC2 individuals.
These samples were prepared by crushing in a sterilized mortar
and pestle. Extraction negative control tubes were always
processed in parallel with tubes containing samples.
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1.0 mg/ml proteinase K) was added to approximately 25 mg of
sample in a sterile 1.5 ml eppendorf tube containing glass beads
and mixed, on a mini bead beater, before incubation at 56uC
overnight. Lysis buffer L6 [28] was then added (250 ml), the tube
vortexed and incubated at 37uC for 2 hours followed by a vortex
mix and centrifugation (1 minute at 13 000 g). The supernatant
was placed in another sterile tube with 25 ml of silica suspension
(12% SiO2 w/v, pH 2.0) vortexed and agitated for 2 hours, to
allow cell lysis and binding of DNA to the silica.
Samples were resuspended, centrifuged for 1 minute at 13 000 g
and the supernatant discarded. The silica was washed with 100 ml
washing buffer L2 [28], then washed twice with 70% (v/v) ethanol
at 220uC, and once with acetone at 220uC. Tubes were drained
on clean, absorbent paper and dried in a 56uC heating block.
DNA was eluted with 50 ml of sterile water (Sigma) and incubation
at 56uC for 30 minutes. This was repeated once then the eluates
were pooled and stored at 220uC.
A nested PCR was used to detect M. tuberculosis by targeting the
repetitive fragment in the genome of the M. tuberculosis complex,
the insertion sequence IS6110. The primers and method are
described by Taylor et al. [20], with amplification of a 123 bp
region of IS6110 using primers P1 and P2 (Table 1) [33]. The
second set of primers (IS3 and IS4) amplifies an internal 92 bp
product (Table 1). Amplification of the RLEP regions in M. leprae
was performed both as standard PCR and as a nested PCR [24]
with amplification of a 129 bp product using the outer primers
LP1 and LP2 (Table 1) which can be nested to a 99 bp product in
the second round of amplification using LP3 and LP4 (Table 1).
Double strength prealiquoted PCR mix from ABgeneH (Epsom,
UK) was used and a final volume of 50 ml (75 mM tris-HCl
pH 8.8, 20 mM (NH4)2SO4, 1.5 mM MgCl2, 0.01% (v/v) tween
20, 200 mM of each nucleotide (dATP, dCTP, dGTP and dTTP),
0.5 mM of each primer; and 1.25 units Taq DNA polymerase) The
primer pair (2.0 mL), BSA (2 mM), and DNA preparation (5.0 ml)
were added to each tube. A control tube with sterile water (Sigma)
in place of template was always included.
Amplification consisted of initial denaturation at 94uC for 1
minute and 25 cycles of: 40 seconds at 94uC, annealing at 1
minute at 68uC (IS6110)o r5 8 uC (RLEP) and 20 seconds at 72uC,
followed by 1 minute at 72uC. For the nested PCR 0.5 mlo f
product, and 2.0 ml of the IS3/IS4 primer pair were added to each
reaction tube and the volume made up to 50 ml. Amplification in
both second stage PCRs followed the first protocol, with primer
annealing at 58uC.
PCR product (7 ml) was added to 3 ml loading buffer (Sigma)
and electrophoresed in a 3.0% (w/v) NuSieve 3:1 agarose gel
(FMC Bioproducts, Flowgen) in TBE buffer (90 mM tris-borate,
2 mM EDTA) or TAE buffer (40 mM Tris-acetate, 1.0 mM
EDTA) at 8.8 volts cm
21for 80 minutes. Amplified DNA was
visualized by ethidium bromide staining exposed under UV light
and was recorded with a Polaroid camera.
PCR product (8.15 ml) was mixed with 4 ml loading buffer and
separated on a gel as above, by electrophoresis with TAE buffer.
The selected band (150–250 mg) was removed from the gel with a
sterile scalpel blade into a sterile 0.5 ml tube. DNA was extracted
from the gel slices using a MERmaid
TM spin kit for samples 10–
200 bp (Anachem, UK). The purified product was then sequenced
by MWG.BIOTECHAG (Ebersberg, Germany).
Stringent precautions were taken to avoid contamination.
Sterile reagents, tubes and plugged tips were used and clean
protective clothing worn, with frequent glove changes. A separate
room with a different set of pipettes was used for handling PCR
product. Pipettes were washed with hydrochloric acid rinsed with
ultrapure water and dried with 70% (v/v) ethanol before use.
Surfaces were cleaned with neat household liquid detergent, rinsed
and dried as above.
Results
Sequences were generated from the analysis of all the Tomb of
the Shroud samples for the HV1 and HV2 of the human mtDNA.
The most consistent sequence amplified was 191 bp between
mitochondrial nucleotide position (np) 16210 and np16401
(Table 2). The mtDNA profiles from these sequences were
analyzed by determining the polymorphisms that occur between
these sequences and the revised Cambridge Reference Sequence
(Table 3). Polymorphisms in this region will be identical in most
maternally related individuals enabling the individuation and
maternal relatedness of remains to be interpreted from a familial
sample population (Table 4). However the target region is small
and thus errors could be introduced in the identification of
relationship amongst a random sample population. This mtDNA
analysis has identified two mtDNA profiles that are shared
between two individuals and one mtDNA profile that is shared
between three individuals, suggesting a number of maternal
relationships within the individuals from the Tomb of the Shroud
(Table 4). The samples were also analyzed to identify their
biological sex using the amelogenin gene and the X and Y
chromosome specific alphoid repeats (Table 5). All extraction and
amplification controls were negative for mtDNA with the primers
used in this study. The archaeologist’s DNA was characterised for
reference to eliminate possible contamination, however neither
contamination nor the archaeologist’s DNA was found in any of
the results.
Skeletal and textile remains from numerous loculi and
environmental samples were examined and analyzed for the
presence of the M. tuberculosis DNA. A fragmented bone with what
may have been a non-specific pathological lesion was discovered in
a collection of archaeological material from the chest region of the
shrouded individual’s loculus. No other osteological indications of
disease were observed from skeletal fragments. Randomly selected
bone fragments were genetically analyzed. A phalange, assorted
skeletal elements, textile samples and the pulp of a molar tooth
from the loculus SC1 (Figure 1) individual were all positive for M.
tuberculosis (Table 5). The positive amplification of M. tuberculosis
obtained from two samples of the SC1 individual was indepen-
dently replicated in the London and Thunder Bay laboratories.
Teeth from two infants in the small ossilegium niche (SC2 T2 and
SC2 T3) in the northern wall of the lower chamber (Figure 1) were
also positive for M. tuberculosis (Table 5). No osseous bone changes
were observed amongst these remains, although infants rarely
survive to an age where M. tuberculosis lesions are evident in the
skeletal material.
The detection method for the M. tuberculosis complex DNA was
based on the extraction and subsequent amplification of the
IS6110 repeat element and the S12 ribosomal protein gene. All
amplifications obtained from archaeological samples were identi-
cal to the NCBI Genbank sequence for IS6110 (sequence X17348,
bases 788–863) and the S12 protein (sequence X70995 in the
NCBI database) (Table 6 and 7). The M. leprae DNA was detected
by amplification of the 18 kDa antigen gene (sequence
MSGANT18K in the NCBI database) and the RLEP repetitive
elements (sequence X17153 in the NCBI database) (Table 8 and
9). Amplification of the mitochondrial DNA from these same
samples and both positive and negative results for pathogenic
DNA from these tombs in addition to logical and expected results
for the haplogroups identified supports authentic results. All
Tomb of the Shroud Genetics
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individuals from the Tomb of the Shroud.
rCRS 16201 CAAGCAAGTA CAGCAATCAA CCCTCAACTA
TCACACATCA ACTGCAACTC
Individual SC1 .......... .......... C.........
..........
Individual SC2 .......... .......... ..........
..........
Individual SC2 .......... .......... ..........
..........
Individual SC2 .......... .......... ..........
..........
Individual SC4 .......... .......... ..........
..........
Individual SC7 .......... .......... ..........
..........
Individual SC7 .......... .......... ..........
..........
Individual SC7 .......... ..T....... ..........
..........
Individual SC9 .......... .......... ..........
..........
Individual SC17.......... ..T....... ..........
..........
Individual SC17.......... .......... ..........
..........
rCRS 16251 CAAAGCCACC CCTCACCCAC TAGGATACCA
ACAAACCTAC CCACCCTTAA
Individual SC1 .......... T......... ..........
.......... ..........
Individual SC2 .......... .......... ..........
.......... ..........
Individual SC2 .......... .......... ..........
.......... ..........
Individual SC2 .......... .......... ..........
.......... ..........
Individual SC4 .......... .......... ..........
.......... .T........
Individual SC7 .......... .......... ..........
.......... .T........
Individual SC7 .......... .......... ..........
.......... .T........
Individual SC7 .......... .......... ..........
.......... .T........
Individual SC9 .......... .......... ..........
.......... ..........
Individual SC17.......... .......... ..........
.......... .T........
Individual SC17.......... T......... ..........
.......... ..........
rCRS 16301 CAGTACATAG TACATAAAGC CATTTACCGT
ACATAGCACA TTACAGTCAA
Individual SC1 .......... .......... ..........
.......... ..........
Individual SC2 .......... .......... ..........
.......... ..........
Individual SC2 .......... .......... ..........
.......... ..........
Individual SC2 .......... .......... ..........
.......... ..........
Individual SC4 .......... .......... ..........
.......... ..........
Individual SC7 .......... .......... ..........
.......... ..........
Individual SC7 .......... .......... ..........
.......... ..........
Individual SC7 .......... .......... ..........
.......... ..........
Individual SC9 .......... .......... ..........
.......... .....C....
Individual SC17.......... .......... ..........
.......... ..........
Individual SC17.......... .......... ..........
.......... ..........
rCRS 16351 ATCCCTTCTC GTCCCCATGG ATGACCCCCC
TCAGATAGGG GTCCCTTGAC
Individual SC1 .......... .......... ..........
.......... ..........
Individual SC2 .......... .......... ..........
.......... ..........
Individual SC2 .......... .......... ..........
.......... ..........
Individual SC2 ...T...... .......... ..........
.......... ..........
Individual SC4 .......... .......... ..........
.......... ..........
Individual SC7 .......... .......... ..........
.......... ..........
Individual SC7 .......... .......... ..........
.......... ..........
Individual SC7 .......... .......... ..........
.......... ..........
Individual SC9 .......... ..G....... ..........
.......... ..........
Individual SC17.......... .......... ..........
.......... ..........
Individual SC17...T...... .......... ..........
.......... ..........
rCRS 16401 CACCATCCTC CGTGAAATCA ATATCCCGCA
CAAGAGTGCT ACTCTCCTCG
Individual SC1 .......... ..........
Individual SC2
Individual SC2 .......... ..........
Individual SC2 .......... ..........
Individual SC4 .......... ..........
Individual SC7
Individual SC7 ...
Individual SC7 .......... ..........
Individual SC9
Individual SC17.......... ..........
Individual SC17.......... ..........
doi:10.1371/journal.pone.0008319.t002
Table 2. Cont.
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pathogenic DNA. No positive PCR results were obtained from
any of the environmental archaeological site control samples for
the presence of M. tuberculosis DNA.
Genetic detection of M. leprae exclusively from the SC1 shroud
loculus individual was also successful. Results have been
successfully replicated in both London and Thunder Bay
laboratories using multiple controls, including environmental soil
samples and tomb wall surface scrapings. All extraction and
amplification controls were negative for pathogenic DNA. No
positive PCR results were obtained from any of the environmental
archaeological site control samples for the presence of M. leprae
DNA. The use of stringent ancient DNA protocol, multiple genetic
targets with 100% sequence homology to pathogenic targets and a
cognitive approach to authentication of mitochondrial DNA
sequence analysis, sex and familial relatedness results was used
to ensure authenticity of our ancient DNA results [39].
Discussion
MtDNA analyses have been performed on the primary loculi
(kokhim) burials and secondary skeletal (ossilegium) deposits from
the first-century C.E. Tomb of the Shroud (SC) found in Jerusalem
to clarify the familial relationship of the tomb occupants. There
were ten samples analyzed from the Tomb of the Shroud loculus,
SC1 (Figure 1). These included one tooth sample, five bone
samples, three textile sample (some with hair associated) and one
hair sample. The analysis included hair samples from the loculus
and hair that was found attached to some of the textile samples. All
of these analyzed samples produced the same human mtDNA
profile (191 bp) and the individual was identified to be male. It was
deemed important to test numerous samples of bone and the
tooth, due to the disturbed nature of the biological remains in the
shroud loculus, and a prior expectation that these loculi were
reused. The mtDNA results indicate that there was only one
individual within the loculus (SC1) that also contained the shroud.
The analysis of the hair attached to the textile and the hair itself,
confirmed the context of the skeletal material associated with the
textile, referred to as a burial shroud that was found in this loculus.
T h e r ew e r ef o u rs a m p l e st e s t e df r o mt h eT o m bo ft h e
Shroud SC2 location (i.e. the ossilegium niche in the north wall
of the lower chamber) (Figure 1). These were identified as a
female and two infants for which their sex was not identified.
The female and one of the infant samples had mtDNA type 2,
and the second infant had mtDNA type 3. The fourth sample
was found to have the same mtDNA type and morphological
size as one of the three individuals concluded to be a replicate
sample.
Table 3. MtDNA polymorphisms and haplotype of individuals from the Tomb of the Shroud.
Individual 16223 16231 16261 16292 16346 16354 16363 MtDNA Type Haplotype
SC1 CT 1
SC2 2H o r V
SC2 2H o r V
SC2 T3 H
SC4 T4 T 3
SC7 T4 T 3
SC7 T4
SC7 TT 5 W
SC9 CG 6
SC17 TT 5 W
SC17 TT 7 H o r J 1
doi:10.1371/journal.pone.0008319.t003
Table 4. Individual characterisation of skeletal remains and possible relatedness from the Tomb of the Shroud.
Individual mtDNA Type Sex Possible Relationships
SC1 1 Adult Male Unrelated
SC2 2 Adult Female Maternally related to one other individual
SC2 2 Infant Indeterminate Maternally related to one other individual
SC2 3 Infant Indeterminate Unrelated
SC4 4 Adult Male Maternally related to two other individuals
SC7 4 Juvenile Female Maternally related to two other individuals
SC7 4 Sex indeterminate Maternally related to two other individuals
SC7 5 Adult Male Maternally related to one other individual
SC9 6 Adult Male Unrelated
SC17 5 Adult Female Maternally related to one other individual
SC17 7 Sex Indeterminate Unrelated
doi:10.1371/journal.pone.0008319.t004
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SC4 location (Figure 1). Both these samples produced the same
mtDNA type 4 and were both found to be male. These two
samples are thus more likely to be from the same individual.
There were four samples tested from the SC7 location (Figure 1).
These were identified as one male and one female with different
mtDNA types (mtDNA type 5 and type 4 respectively). However,
the third sample contained a mtDNA sequence that matched one
of the previous samples (mtDNA type 4). These two samples are
more than likely to be from the same individual rather than that of
two related persons. However, the genetic sex analysis of this
sample was indeterminate and unable to clarify this issue. The
fourth sample tested from SC7 did not produce a reliable mtDNA
sequence but produced an IS6110 sequence and was not included
in the study thereafter.
There was only one sample tested from the SC9 location
(Figure 1). This sample was identified as a male with mtDNA type
6, which did not match any other member of the tomb that was
tested. From SC17 there were two samples tested (Figure 1). These
produced one female sample and one sex indeterminate sample.
These samples both had different mtDNA types, the female
mtDNA type 5 and the other mtDNA type 7. The type 7 sample
did not match any other sample in the tomb.
Relatedness Analysis
From this analysis there have been identified two maternally
unrelated male individuals (both adults from SC1 and SC9), two
maternally unrelated sex indeterminate individuals (one adult
SC17 and one infant SC2) and two maternally related pairs of
individuals (adult female SC2 and infant SC2 and adult female
SC17 and adult male SC7). If the third sample from SC7 has the
correct provenance, then this is potentially a group of three
maternally related individuals (adult male SC4, juvenile female
SC7 and sex indeterminate SC7).
Textile
Mitochondrial DNA analysis confirmed the locks of hair were
contextually associated with the skeletal remains found in loculus
SC1. The mtDNA analysis also confirmed the textile was
associated with the hair found in loculus SC1 and that the textile
was draped or shrouded over the hair and head region. It was also
identified that the textile was present adhering to biological
Table 5. The archaeological samples analyzed from the Tomb of the Shroud (SC) and the molecular results for each genetic target.
Sample Tested Description Haplo mtDNA Sexing M. tuberculosis M. leprae
1
st 2
nd 3
rd 4
th Amel ARX ARY S12 IS6110 RLEP 18kDa
SC1 T1
a Tooth +++2 + 2 +++ ++
SC1 B1
a Bone fragment 22222 2222 22
SC1 B2
a Bone fragment +++2 22222 22
SC1 B3
a Phalange 2 + 2 2 22222 22
SC1 B4
ab Bone fragment +++22 ++++ ++
SC1 B5
ab Phalange 2 + 222 2 2 ++ ++
SC1 F1 Textile (white fibers) 22222 2222 22
SC1 F2 Textile (brown fibers) 22222 2222 22
SC1 F3 Textile (wool fibers) 2 + 222 2 2 ++ 22
SC1 H1 Human hair 2 ++2 22222 22
SC2 T1
ab Adult molar tooth H, V 2 ++22 + 2 ++ 22
SC2 T2
b Infant tooth H, V 2 + 222 2 2 2 + 22
SC2 T3
a Infant tooth H ++2 2 22222 22
SC2 B1 Infant bone fragment H 2 + 2 2 22222 22
SC4 T1 Adult tooth crown T3 2 + 222 2 + 22 22
SC4 T2
a Adult tooth T3 +++++ + + 22 22
SC7 T1
a Juvenile incisor piece T3 2 + 222 ++22 22
SC7 T2
a Small molar (broken) W +++2 ++222 22
SC7 B1
a Phalange 22222 2 2 2 + 22
SC7 B2 Small phalange W 2 + 2 2 22222 22
SC9 T1
a Adult male canine +++2 +++22 22
SC17 T1
a Premolar tooth W +++2 ++222 22
SC17 T2
a Adult molar crown H, J1 2 ++2 22222 22
SC1 R Soil sample 22222 2222 22
SC1 RW Soil sample 22222 2222 22
SC1 LW Soil sample 22222 2222 22
The mitochondrial DNA amplification is represented as; 1
st mt15975F-mt16322R; 2
nd mt16190F-mt16420R; 3
rd mt1F or mt15F-mt279R; and 4
th mt155F-mt429R. a –
indicates samples replicated at the Paleo-DNA Laboratory, b – indicates samples replicated at UCL (only mycobacterial results replicated), + indicates a positive result,
- indicates a negative result. SC - corresponds to the Tomb of the Shroud loculus location numbers from the original tomb plan (Figure 1), T - corresponds to Tooth, B -
corresponds to Bone and F - corresponds to Textile.
doi:10.1371/journal.pone.0008319.t005
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the body of the individual in loculus SC1.
The haplotype designations for mtDNA analyses are population
categorizations that have been used extensively in the past to infer
population movements [10]. The haplotypes for the Tomb of the
Shroud individuals are commonly distributed throughout the
North of Africa and the Middle East through to Eastern Europe.
The tomb occupants exhibit a number of different maternal
Table 6. Alignment of M. tuberculosis IS6110 repeat element and sequence data from SC1 exhibiting complete sequence
homology.
M. tuberculosis CGTGAGGGCATCGAGGTGGCCAGATGCACCGTCGAACGGCTGATGACCAA
SC1 concensus ..................................................
SC2 concensus ..................................................
SC2 concensus ..................................................
SC7 concensus ..................................................
M.tuberculosis ACTCGGCCTGTCCGGGACCACCCGCGGCAAAGCCCGCAGGACCACGATCG
SC1 concensus ..................................................
SC2 concensus ..................................................
SC2 concensus ..................................................
SC7 concensus ..................................................
M.tuberculosis CTGATCCGGCCACAGCCCGTCCCGCCGATCTCGTCCAGCGCCGCTTCGGA
SC1 concensus ..................................................
SC2 concensus ..................................................
SC2 concensus ..................................................
SC7 concensus ..................................................
M.tuberculosis CCACCAGCACCTAACCGGCTGTGGGTAGCAGACCTCACCTATGTGTCGAC
SC1 concensus ..................................................
SC2 concensus ..................................................
SC2 concensus ..................................................
SC7 concensus ..................................................
M.tuberculosis CTGGGCAGGGTTCGCCTACGTGGCCTTTGTCACCGACGCCTACGTCGC
SC1 concensus ................................................
SC2 concensus ................................................
SC2 concensus ................................................
SC7 concensus ................................................
*Underlined sequence denotes the primer binding region.
Aligned to the IS6110 sequence from Genbank, accession number X17348.
doi:10.1371/journal.pone.0008319.t006
Table 7. Alignment of M. tuberculosis gene for ribosomal protein S12 with sequence data from SC1.
M.tuberculosis TCGTCGGGACAAGATCAGTAAGGTCAAGACCGCGGCTCTGAAGGGCAGCC
SC1 ..................................................
M. tuberculosis CGCAGCGTCGTGGTGTATGCACCCGCGTGTACACCACCACTCCGAAGAAG
SC1 ..................................................
M. tuberculosis CCGAACTCGGCGCTTCGGAAGGTTGCCCGCGTGAAGTTGACGAGTCAGGT
SC1 ..................................................
M. tuberculosis CGAGGTCACGGCGTACATTCCCGGCGAGGGCCACAACCTGCAGGAGCACT
SC1 ..................................................
M. tuberculosis CGAT
SC1 ....
*Underlined sequence denotes the primer binding region.
Aligned to the S12 sequence from Genbank, accession number X70995.
doi:10.1371/journal.pone.0008319.t007
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inferences that this Akeldama site was a family tomb which was in
use in the first-century C.E.
A selection of osteological elements from the Tomb of the
Shroud in the Hinnom valley has been genetically analyzed to
investigate the presence of disease in this unusual occurrence of a
primary burial of a shrouded individual walled off, using rock and
plaster, within the tomb. This is a unique archaeological discovery,
suggesting it might have been intentionally kept sealed by family
members who feared the visual aspects of disease.
Pathology was suspected in the anthropological examination of
human remains from SC1 (made by D. Sklar). A bone with an
advanced lesion was later identified in a collection of bones from
the chest region of the SC1 individual. The presence of this lesion
supports the genetic identification of M. tuberculosis bacilli in all the
skeletal elements analyzed and the severe nature of the infection.
The positive results from the textile sample could be produced
from the infected blood and biological material that was found to
be adhered to the textile. There were no bone lesions identified in
remains from SC2, although infants rarely survive long enough for
tuberculosis bone lesions to form.
The mitochondrial DNA profile was not obtained for one of the
SC7 samples for which we are unable to resolve the provenance.
The differential preservation of mitochondrial and pathogenic
DNA has been noted in many cases as the amplification intensity
of pathogenic DNA, is far greater than the amplification intensity
of mitochondrial DNA suggesting a higher concentration of
pathogenic DNA template.
The identification of M. tuberculosis from an individual
approximately 2,000 years ago is consistent with our current
understanding of Mycobacterium infection and transmission between
humans and in humans and domesticated animals [40].
Mycobacterium bovis is a distinct pathogenic species in bovids,
appearing with domestication in the Middle East, is not common
in human populations, and has only once been confirmed in the
past by biomolecular analysis of archaeological material [41]. The
first pathogenic Mycobacterium to arise and its host population is a
contentious issue and may be resolved with future molecular
research on archaeological samples and the hunt for a progenitor
or an intermediate M. tuberculosis/M. bovis species [41,42,43].
Tuberculosis is an opportunistic pathogenic disease common
and generally fatal in antiquity throughout Europe and the Middle
East. The shrouded individual (SC1) and two infants (SC2) were
genetically confirmed to contain the DNA from M. tuberculosis.
Identification of M. tuberculosis from the tooth pulp of these
individuals suggests that this pathogen was in the bloodstream and
therefore throughout the body as miliary tuberculosis and all three
individuals would have almost certainly have died from a
disseminated bacterial infection.
The three M. tuberculosis positive individuals do not appear to be
maternally related, they may however be paternally related (this will
be investigated in future Y chromosome analyses). The skeletal
remains in the wall niche were those of the two infants with
tuberculosis and a maternally related adult female, possibly the
mother. Future genetic work using SNP typing of the pathogen
infecting each individual may identify the epidemiological transmis-
sion pattern of this pathogen amongst individuals within this tomb.
There have been few genetically confirmed cases of pathological
Mycobacterium spp. infections in Israel. Rafi et al. [18] published the
first molecular identification of leprosy, M. leprae, in archaeological
samples from Israel, followed by the amplification of M. leprae from
a Madura foot dating from the Byzantine period [44]. The
molecular identification of M. leprae from SC1 in the first-century
C.E. Tomb of the Shroud is the earliest molecularly confirmed
case of leprosy (Hansen’s Disease) from Israel. In the Near East
leprosy is not generally thought to predate the Hellenistic period
and the troops of Alexander the Great (327–326 B.C.E) were
thought to be the ones responsible for bringing this deadly disease
Table 8. Alignment of M. leprae 18 kDa gene region with sequence data from SC1.
M. leprae ATCGACTGTTGTTTGCGCAACAAGCTAAGCACGAAGCTAAGCACGCCGCT
SC1 ..................................................
M. leprae GCGGTCAAAAGCCCGTCTTAGCCATGGATCTTTAAAGTATCCGAACATTT
SC1 ..................................................
M. leprae CGGTTGCTGG
SC1 ..........
*Underlined sequence denotes the primer binding region.
Aligned to the 18 kDa gene sequence from Genbank, accession number MSGANT18K.
doi:10.1371/journal.pone.0008319.t008
Table 9. Alignment of M. leprae RLEP gene region with sequence from SC1.
M. leprae TGCATGTCATGGCCTTGAGGTGTCGGCGTGGTCAATGTGGCCGCACCTGA
SC1 ..................................................
M. leprae ACAGGCACGTAAAAGTGCACGGTATAACTATTCGCACCTGATGTTATCCC
SC1 ..................................................
M. leprae TTGCACCATTTCTGCCGCTGGTATCGGTG
SC1 .............................
*Underlined sequence denotes the primer binding region.
Aligned to the RLEP gene sequence from Genbank, accession number X17153.
doi:10.1371/journal.pone.0008319.t009
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[45] suggests that leprosy may have first appeared in the region not
with Alexander but sometime earlier (circa 400 B.C.E or later),
with diseased young slaves conveyed from India to Egypt on cargo
ships. More recently a review of the origins and spread of leprosy
has identified an East African origin with various routes of
migration out of Africa into the Middle East and beyond [46].
Leprosy was, and still is associated with enormous social stigma,
and individuals could have been ostracized from their communi-
ties. The health of expelled lepromatous individuals is probably
compromised, without assistance for food procurement or an
income. On infection the individual becomes immuno-compro-
mised and the chance of co-infection by M. tuberculosis and other
pathogens occurs. However, a number of indications – the
location and size of the tomb, the type of textiles used as shroud
wrappings, the clean state of the hair – suggest that the shrouded
individual was a fairly affluent member of society in Jerusalem and
that tuberculosis crossed social boundaries in the first century C.E.
It is interesting to note that the skeletal remains from within the
plaster-sealed parts of the tomb (SC1 and SC2) are positive for M.
tuberculosis and one of them for both M. tuberculosis and M. leprae.
There appears to be a correlation therefore between the presence of
disease in the human remains and the isolation of those remains
even when these remains had undergone secondary burial (as with
the wall niche remains - SC2). Sealing parts of the tomb with white
plaster is generally rare in first-century C.E. tombs in Jerusalem.
Thus it would suggest that these remains were intentionally sealed.
However, as previously mentioned, the individuals from the wall
niche undoubtedly underwent secondary burial, meaning that their
bones were extracted from a loculus and placed into the niche.
The presence of both M. tuberculosis and M. leprae DNA is
associated with immuno-suppressed individuals, which is a feature
of the multi-bacillary or lepromatous form of leprosy. Indeed, in
historical times leprosy patients were often reported to have died
due to the more aggressive M. tuberculosis infection [47,48,49]. A
secondary co-infection of tuberculosis, in Hansen’s patients is
found in 25% of modern cases [50], and up to one-third of the
world’s population is currently infected with tuberculosis (WHO
2007: World Health Organisation: http://www.who.int/tb). The
co-infection of leprosy with tuberculosis is often the cause of death
as M. leprae infection generates a compromised immune system,
vulnerable to a subsequent M. tuberculosis infection that is still fatal
in some parts of the world today. The finding of co-infection in the
shrouded individual stimulated us to review all our positive M.
leprae cases and resulted in a hypothesis being proposed as to why
leprosy disappeared from Europe in Medieval times [27].
Due to the highly degraded nature of the skeletal remains from
the Hinnom Valley tomb and the disturbed archaeological context
of the individuals, molecular sex determination, mtDNA for
maternal familial relationships and molecular paleopathology
dramatically enhanced the significance of this archaeological site.
Three individuals were detected with tuberculosis, all of which
were recovered from plaster sealed locations. A co-infection of
tuberculosis and leprosy was an unexpected discovery in the
remains of the shrouded individual and present a significant and
unique anthropological example of contagious disease in the past.
Conclusion
The Tomb of the Shroud suffered from illegal and clandestine
digging operations before archaeologists reached the site, and this
resulted in the disturbed nature of the degraded human remains
and limited the physical anthropological examination. Genetic
analysis confirmed the archaeologist’s interpretation of this tomb
as a family tomb containing a number of generations and provided
important information on the bioarchaeology not available
through skeletal analysis.
The presence of M. tuberculosis and M. leprae in these individuals
within the Tomb of the Shroud is significant for the geographical
and temporal distribution of tuberculosis and leprosy in the past. It
confirms the presence of tuberculosis using molecular methods and
is the oldest molecular confirmation of both M. tuberculosis and M.
leprae in Jerusalem. Co-infection present a plausible explanation for
the unusual and extreme lengths people went to in order to
contain what was recognized as a seriously debilitating affliction.
This analysis found that the shroud loculus individual and two
infants from the same tomb suffered from M. tuberculosis infection.
The prevalence of such a highly contagious disease, particularly
for immuno-compromised individuals with leprosy is not unex-
pected with inadequate sanitation and demonstrates the significant
impact social diseases such as tuberculosis had on society from the
low socioeconomic groups up to the more affluent families, such as
Tomb the Shroud in first-century Jerusalem.
Molecular archaeology and the identification of pathogenic
DNA contribute greatly to the confirmation of pathologies and
direct identification of disease in fragmented and degraded
material such as this tomb. The molecular identification of
tuberculosis in the Jerusalem tomb is a significant contribution to
the archaeological interpretation of this site and suggests a reason
for the plaster sealing of the loculus containing the shrouded man
and for the additional individuals sealed in the wall niche.
Molecular pathology adds a new dimension to the archaeological
exploration of disease in ancient times, especially in regard to the
remains of infants where there is an absence of bone pathologies.
The discovery and successful genetic analyses of unique archae-
ological sites such as Tomb of the Shroud poses great promise for
future investigations into the host-pathogen relationships and
evolution, geographic distribution and epidemiology of disease and
social health in the past.
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